This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Calroy Health Sciences, LLC, Macau Glcao Biotechnology Research Center Limited. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 1 Years Active: 2022
Title: The Innovative Contributions of Jinhua Wei
Introduction
Jinhua Wei, an inventor based in Jiangsu, China, has made significant strides in the field of biotechnology. With a keen focus on developing methods to combat endothelial glycocalyx-related diseases, Wei's work epitomizes the intersection of innovation and health sciences.
Latest Patents
Jinhua Wei holds a patent for a "Method and apparatus for screening compounds that have preventative and therapeutic activities against endothelial glycocalyx-related diseases." This innovative technology utilizes a microfluidic chip that includes a multichamber flow assembly featuring numerous microchannels. These channels are designed to facilitate the screening of biomolecules, enabling a better understanding of their movement and interactions, critical for advancing therapeutic approaches in this vital area of health.
Career Highlights
Throughout her career, Jinhua Wei has collaborated with reputable organizations. She has worked with the Macau Glyco Biotechnology Research Center Limited and Calroy Health Sciences, LLC. Her experience in these companies highlights her commitment to advancing scientific research and developing practical applications for healthcare improvements.
Collaborations
Wei has collaborated with notable colleagues, including Yong Luo and Zhou Wang. These partnerships reflect a synergistic approach to research, which is vital for driving innovations in biotechnology. Each collaboration aims to enhance the understanding of complex biological systems and promote the development of effective treatments.
Conclusion
Jinhua Wei's contributions to the field of biotechnology are commendable, showcasing the potential of her inventions to address critical health issues. Her patented technology represents a significant advancement in the screening of compounds and carries implications for therapeutic development. As she continues her work in this domain, the impact of her innovations will undoubtedly resonate within the medical research community and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile